# Endothelial Monocyte-activating Polypeptide-II in Egyptian Sickle Patients

> **NCT03903133** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 50 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Vitamin E

## Key facts

- **NCT ID:** NCT03903133
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03903133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03903133, "Endothelial Monocyte-activating Polypeptide-II in Egyptian Sickle Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03903133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*